Evaluation of MALDI-TOF mass spectrometry for the identification of medically-important yeasts in the clinical laboratories of Dijon and Lille hospitals

References

• Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007; 20: 133–163.
   PubMed Web of Science ®Google Scholar
• Groll AH, Walsh TJ. Uncommon opportunistic fungi: new nosocomial threats. Clin Microbiol Infect 2001; 7: 8–24.
   PubMed Web of Science ®Google Scholar
• Nucci M, Marr KA. Emerging fungal diseases. Clin Infect Dis 2005; 41: 521–526.
   PubMed Web of Science ®Google Scholar
• Atkinson BJ, Lewis RE, Kontoyiannis DP. Candida lusitaniae fungemia in cancer patients: risk factors for amphotericin B failure and outcome. Med Mycol 2008; 46: 541–546.
   PubMed Web of Science ®Google Scholar
• Chen SC, Marriott D, Playford EG, . Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management. Clin Microbiol Infect 2009; 15: 662–669.
   PubMed Web of Science ®Google Scholar
• Girmenia C, Pagano L, Martino B, . Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature. J Clin Microbiol 2005; 43: 1818–1828.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ. Epidemiology of invasive mycoses in North America. Crit Rev Microbiol 2010; 36: 1–53.
   PubMed Web of Science ®Google Scholar
• Ruan SY, Huang YT, Chu CC, Yu CJ, Hsueh PR. Candida glabrata fungaemia in a tertiary centre in Taiwan: antifungal susceptibility and outcomes. Int J Antimicrob Agents 2009; 34: 236–239.
   PubMed Web of Science ®Google Scholar
• Cuenca-Estrella M, Gomez-Lopez A, Isla G, . Prevalence of Candida bracarensis and Candida nivariensis in a Spanish collection of yeasts: comparison of results from a reference centre and from a population-based surveillance study of candidemia. Med Mycol 2011; 49: 525–529.
   PubMed Web of Science ®Google Scholar
• Espinel-Ingroff A. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature. Rev Iberoam Micol 2003; 20: 121–136.
   PubMedGoogle Scholar
• Fujita S, Senda Y, Okusi T, . Catheter-related fungemia due to fluconazole-resistant Candida nivariensis. J Clin Microbiol 2007; 45: 3459–3461.
   PubMed Web of Science ®Google Scholar
• Lockhart SR, Messer SA, Gherna M, . Identification of Candida nivariensis and Candida bracarensis in a large global collection of Candida glabrata isolates: comparison to the literature. J Clin Microbiol 2009; 47: 1216–1217.
   PubMed Web of Science ®Google Scholar
• Marr KA. The changing spectrum of candidemia in oncology patients: therapeutic implications. Curr Opin Infect Dis 2000; 13: 615–620.
   PubMed Web of Science ®Google Scholar
• Marr KA, Seidel K, White TC, Bowden RA. Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. J Infect Dis 2000; 181: 309–316.
   PubMed Web of Science ®Google Scholar
• Miceli MH, Diaz JA, Lee SA. Emerging opportunistic yeast infections. Lancet Infect Dis 2011; 11: 142–151.
   PubMed Web of Science ®Google Scholar
• De Rosa FG, Garazzino S, Pasero D, Di Perri G, Ranieri VM. Invasive candidiasis and candidemia: new guidelines. Minerva Anestesiol 2009; 75: 453–458.
   Google Scholar
• Maertens J, Marchetti O, Herbrecht R, . European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3 – 2009 update. Bone Marrow Transplant 2011; 46: 709–718.
   PubMed Web of Science ®Google Scholar
• Pappas PG, Kauffman CA, Andes D, . Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 503–535.
   PubMed Web of Science ®Google Scholar
• Loiez C, Wallet F, Sendid B, Courcol RJ. Evaluation of VITEK 2 colorimetric cards versus fluorimetric cards for identification of yeasts. Diagn Microbiol Infect Dis 2006; 56: 455–457.
   PubMed Web of Science ®Google Scholar
• Pincus DH, Orenga S, Chatellier S. Yeast identification – past, present, and future methods. Med Mycol 2007; 45: 97–121.
   PubMed Web of Science ®Google Scholar
• Borman AM, Petch R, Linton CJ, . Candida nivariensis, an emerging pathogenic fungus with multidrug resistance to antifungal agents. J Clin Microbiol 2008; 46: 933–938.
   PubMed Web of Science ®Google Scholar
• Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE, Coleman DC. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 1995; 141: 1507–1521.
   PubMed Web of Science ®Google Scholar
• Garner CD, Starr JK, McDonough PL, Altier C. Molecular identification of veterinary yeast isolates by use of sequence-based analysis of the D1/D2 region of the large ribosomal subunit. J Clin Microbiol 2010; 48: 2140–2146.
   PubMed Web of Science ®Google Scholar
• Leaw SN, Chang HC, Sun HF, . Identification of medically important yeast species by sequence analysis of the internal transcribed spacer regions. J Clin Microbiol 2006; 44: 693–699.
   PubMed Web of Science ®Google Scholar
• Cornet M, Sendid B, Fradin C, . Molecular identification of closely related Candida species using two ribosomal intergenic spacer fingerprinting methods. J Mol Diagn 2011; 13: 12–22.
   Google Scholar
• Bader O, Weig M, Taverne-Ghadwal L, . Improved clinical laboratory identification of human pathogenic yeasts by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Microbiol Infect 2011; 17: 1359–1365.
   PubMed Web of Science ®Google Scholar
• Bizzini A, Durussel C, Bille J, Greub G, Prod'hom G. Performance of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of bacterial strains routinely isolated in a clinical microbiology laboratory. J Clin Microbiol 2010; 48: 1549–1554.
   PubMed Web of Science ®Google Scholar
• Croxatto A, Prod'hom G, Greub G. Applications of MALDI-TOF mass spectrometry in clinical diagnostic microbiology. FEMS Microbiol Rev 2012; 36: 380–407.
   PubMed Web of Science ®Google Scholar
• Dhiman N, Hall L, Wohlfiel SL, Buckwalter SP, Wengenack NL. Performance and cost analysis of matrix-assisted laser desorption ionization-time of flight mass spectrometry for routine identification of yeast. J Clin Microbiol 2011; 49: 1614–1616.
   PubMed Web of Science ®Google Scholar
• Pinto A, Halliday C, Zahra M, . Matrix-assisted laser desorption ionization-time of flight mass spectrometry identification of yeasts is contingent on robust reference spectra. PLoS One 2011; 6: e25712.
   PubMed Web of Science ®Google Scholar
• Putignani L, Del Chierico F, Onori M, . MALDI-TOF mass spectrometry proteomic phenotyping of clinically relevant fungi. Mol Biosyst 2011; 7: 620–629.
   PubMedGoogle Scholar
• Stevenson LG, Drake SK, Shea YR, Zelazny AM, Murray PR. Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of clinically important yeast species. J Clin Microbiol 2010; 48: 3482–3486.
   PubMed Web of Science ®Google Scholar
• van Veen SQ, Claas EC, Kuijper EJ. High-throughput identification of bacteria and yeast by matrix-assisted laser desorption ionization-time of flight mass spectrometry in conventional medical microbiology laboratories. J Clin Microbiol 2010; 48: 900–907.
   PubMed Web of Science ®Google Scholar
• Alanio A, Beretti JL, Dauphin B, . Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for fast and accurate identification of clinically relevant Aspergillus species. Clin microbiol Infect 2011; 17: 750–755.
   PubMed Web of Science ®Google Scholar
• Marklein G, Josten M, Klanke U, . Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates. J Clin Microbiol 2009; 47: 2912–2917.
   PubMed Web of Science ®Google Scholar
• Lott TJ, Kuykendall RJ, Reiss E. Nucleotide sequence analysis of the 5.8S rDNA and adjacent ITS2 region of Candida albicans and related species. Yeast 1993; 9: 1199–1206.
   PubMed Web of Science ®Google Scholar
• Kaleta EJ, Clark AE, Cherkaoui A, . Comparative analysis of PCR-electrospray ionization/mass spectrometry [MS] and MALDI-TOF/MS for the identification of bacteria and yeast from positive blood culture bottles. Clin Chem 2011; 57: 1057–1067.
   PubMed Web of Science ®Google Scholar
• Schubert S, Weinert K, Wagner C, . Novel, improved sample preparation for rapid, direct identification from positive blood cultures using matrix-assisted laser desorption/ionization time-of-flight [MALDI-TOF] mass spectrometry. J Mol Diagn 2011; 13: 701–706.
   PubMed Web of Science ®Google Scholar
• Seyfarth F, Wiegand C, Erhard M, . Identification of yeast isolated from dermatological patients by MALDI-TOF mass spectrometry. Mycoses 2012; 55: 276–280.
   PubMed Web of Science ®Google Scholar
• Van Herendael BH, Bruynseels P, Bensaid M, . Validation of a modified algorithm for the identification of yeast isolates using matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry [MALDI-TOF MS]. Eur J Clin Microbiol Infect Dis 2012; 31: 841–848.
   PubMed Web of Science ®Google Scholar
• Marinach-Patrice C, Fekkar A, Atanasova R, . Rapid species diagnosis for invasive candidiasis using mass spectrometry. PLoS One 2010; 5: e8862.
   PubMed Web of Science ®Google Scholar
• Marinach C, Alanio A, Palous M, . MALDI-TOF MS-based drug susceptibility testing of pathogens: the example of Candida albicans and fluconazole. Proteomics 2009; 9: 4627–4631.
   PubMed Web of Science ®Google Scholar
• Qian J, Cutler JE, Cole RB, Cai Y. MALDI-TOF mass signatures for differentiation of yeast species, strain grouping and monitoring of morphogenesis markers. Anal Bioanal Chem 2008; 392: 439–449.
   PubMed Web of Science ®Google Scholar
• Hettick JM, Green BJ, Buskirk AD, . Discrimination of Aspergillus isolates at the species and strain level by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry fingerprinting. Anal Biochem 2008; 380: 276–281.
   PubMed Web of Science ®Google Scholar
• Theel ES, Hall L, Mandrekar J, Wengenack NL. Dermatophyte identification using matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 2011; 49: 4067–4071.
   PubMed Web of Science ®Google Scholar
• Kemptner J, Marchetti-Deschmann M, Mach R, . Evaluation of matrix-assisted laser desorption/ionization [MALDI] preparation techniques for surface characterization of intact Fusarium spores by MALDI linear time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 2009; 23: 877–884.
   PubMed Web of Science ®Google Scholar
• Seyfarth F, Ziemer M, Sayer HG, . The use of ITS DNA sequence analysis and MALDI-TOF mass spectrometry in diagnosing an infection with Fusarium proliferatum. Exp Dermatol 2008; 17: 965–971.
   PubMed Web of Science ®Google Scholar
• Rogers PD, Vermitsky JP, Edlind TD, Hilliard GM. Proteomic analysis of experimentally induced azole resistance in Candida glabrata. J Antimicrob Chemother 2006; 58: 434–438.
   PubMed Web of Science ®Google Scholar